Mostrar o rexistro simple do ítem

dc.contributor.authorRegueiro Lorenzo, Uxía*
dc.contributor.authorLópez-López, M.*
dc.contributor.authorVarela-Fernández, R.*
dc.contributor.authorOtero Espinar, Francisco*
dc.contributor.authorLema Gesto, Isabel*
dc.date.accessioned2025-09-08T11:46:55Z
dc.date.available2025-09-08T11:46:55Z
dc.date.issued2023
dc.identifier.citationRegueiro U, López-López M, Varela-Fernández R, Otero-Espinar FJ, Lema I. Biomedical Applications of Lactoferrin on the Ocular Surface. Pharmaceutics. MDPI; 2023;15(3).
dc.identifier.issn1999-4923
dc.identifier.otherhttps://portalcientifico.sergas.gal//documentos/643af69e1656ab66db7e0684
dc.identifier.urihttp://hdl.handle.net/20.500.11940/21158
dc.description.abstractLactoferrin (LF) is a first-line defense protein with a pleiotropic functional pattern that includes anti-inflammatory, immunomodulatory, antiviral, antibacterial, and antitumoral properties. Remarkably, this iron-binding glycoprotein promotes iron retention, restricting free radical production and avoiding oxidative damage and inflammation. On the ocular surface, LF is released from corneal epithelial cells and lacrimal glands, representing a significant percentage of the total tear fluid proteins. Due to its multifunctionality, the availability of LF may be limited in several ocular disorders. Consequently, to reinforce the action of this highly beneficial glycoprotein on the ocular surface, LF has been proposed for the treatment of different conditions such as dry eye, keratoconus, conjunctivitis, and viral or bacterial ocular infections, among others. In this review, we outline the structure and the biological functions of LF, its relevant role at the ocular surface, its implication in LF-related ocular surface disorders, and its potential for biomedical applications.
dc.description.sponsorshipThis study was partially supported by grants from Xunta de Galicia (U.R.: IN606B-2021/001 and GRC ED431C2021/26), the Spanish Ministry of Economy and Competitiveness (RTI2018-099597-B-100) and Instituto de Salud Carlos III (ISCIII) (I.L.: PI18/00159), and the Spanish Research Network on Cerebrovascular Diseases INVICTUS PLUS (M.L.-L.: RD16/0019/0001). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.
dc.languageeng
dc.rightsAttribution 4.0 International (CC BY 4.0)*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.titleBiomedical Applications of Lactoferrin on the Ocular Surface
dc.typeArtigo
dc.authorsophosRegueiro, U.; López-López, M.; Varela-Fernández, R.; Otero-Espinar, F.J.; Lema, I.
dc.identifier.doi10.3390/pharmaceutics15030865
dc.identifier.sophos643af69e1656ab66db7e0684
dc.issue.number3
dc.journal.titlePharmaceutics*
dc.organizationServizo Galego de Saúde::Áreas Sanitarias (A.S.) - Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS)
dc.organizationServizo Galego de Saúde::Áreas Sanitarias (A.S.) - Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS)
dc.organizationIngo - Fundación Pública Instituto Galego de Oftalmoloxía::Oftalmoloxía
dc.relation.projectIDXunta de Galicia [U.R.: IN606B-2021/001, GRC ED431C2021/26]
dc.relation.projectIDSpanish Ministry of Economy and Competitiveness [RTI2018-099597-B-100]
dc.relation.projectIDInstituto de Salud Carlos III (ISCIII) [PI18/00159]
dc.relation.projectIDSpanish Research Network on Cerebrovascular Diseases INVICTUS PLUS [RD16/0019/0001]
dc.relation.publisherversionhttps://doi.org/10.3390/pharmaceutics15030865
dc.rights.accessRightsopenAccess*
dc.subject.keywordAS Santiago
dc.subject.keywordIDIS
dc.subject.keywordAS Santiago
dc.subject.keywordIDIS
dc.subject.keywordINGO
dc.typefidesArtículo Científico (incluye Original, Original breve, Revisión Sistemática y Meta-análisis)
dc.typesophosArtículo de Revisión
dc.volume.number15


Ficheiros no ítem

Este ítem aparece na(s) seguinte(s) colección(s)

Mostrar o rexistro simple do ítem

Attribution 4.0 International (CC BY 4.0)
A non ser que se indique outra cousa, a licenza do ítem descríbese comoAttribution 4.0 International (CC BY 4.0)